Advertisement

Pharmaceutical Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X
X

Lonza Biologics Plant Expansion

Order year

2000

Project type

Facility expansion

Location

New Hampshire, USA

Estimated investment

$207m, phase three $300m (€220m)

Completion

August 2004, Phase three mid-2008

Sponsor

Lonza Biologics

Lead contractor

Parsons, US (www.parsons.com)

Subcontractors

Emerson Process Management, US

 

Kinetics Modular Systems (KMS), US

 

PROCONEX, US

 

New England Controls, US

Appledore Engineering

Output chemicals

Therapeutic proteins and monoclonal antibodies

Units/tablets (year)

Phase two quadrupled capacity and now phase three is addressing mid-scale production
Expand

Free download worth over $5000
Download our 2019 Technology, Media and Telecoms Predictions Report

Worth up to $5,850

In this report, we look at the 30 big tech themes for 2019, identifying winners and losers for each theme. This report will impact all industries helping:

  • CEOs/Senior Staff: in all industries understand the disruptive threats to their competitive landscape
  • Investors: Helps fund managers focus their time on the most interesting investment opportunities in global TM
Close
Close
Close

Go Top